pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·8h ago·1 min read
save

Trump administration eyes Heidi Overton as next FDA commissioner

Aug 19, 2026·read at BioPharma Dive ↗RegulatoryNeutral

President Donald Trump is reported to be preparing a nomination for Heidi Overton to become the next commissioner of the Food and Drug Administration, according to multiple news outlets.

Overton is a medical doctor who completed a general surgery residency at Johns Hopkins University. She later served as a White House fellow in the first Trump administration and, after the 2020 election, became chief policy officer at the America First Policy Institute, leading its Center for a Healthy America.

If confirmed by the Senate, Overton would replace interim deputy commissioner Kyle Diamantas, who has been running the agency since Marty Makary stepped down in May. The FDA has faced significant turnover and staff reductions during the current administration, raising questions about the direction of its regulatory agenda.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “Trump reportedly plans to tap policy aide Overton to lead FDA”

read at BioPharma Dive ↗
597 words · retrieved 7h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Johns Hopkins University2LEADING
topics
Oncology

related stories

  • Jul 16Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical expertsSTAT
  • Jun 11Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850STAT
  • Jun 1The hidden history of BPC-157, a favorite MAHA peptideSTAT
  • May 15PSA screening for prostate cancer reduces disease-specific deaths, new review showsSTAT
  • Apr 27New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies projectSTAT